Treace Medical Concepts

TMCI

Market cap $258M

TMCI Hedge Fund Activity: Q1 2026 in Review

118 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2026, worth a combined $48.3M — down 45% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new TMCI positions and 25 closed out — a net gain of 7 holders — while 35 added to existing stakes and 28 trimmed.

The largest buyer was Gagnon Securities, adding an estimated $4.17M. The largest seller was Gagnon Advisors, exiting entirely with an estimated $3.76M sold.

• 118 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2026, up from 115 in Q4 2025.
• Funds reported $48.3M of Treace Medical Concepts stock for Q1 2026, down 45% quarter-over-quarter.
• 32 funds opened new Treace Medical Concepts positions in Q1 2026 and 25 closed out, a net change of +7 holders.
• The largest Treace Medical Concepts buyer in Q1 2026 was Gagnon Securities, an estimated $4.17M added.
• The largest Treace Medical Concepts seller in Q1 2026 was Gagnon Advisors, an estimated $3.76M sold.

Based on aggregated 13F filings for Q1 2026.